HCM — HUTCHMED (China) Share News
0.000.00%
Last trade - 00:00
- £2.69bn
- £2.15bn
- $838.00m
REG - Hutchmed China Ltd - Holding(s) in Company
AnnouncementRCS - Hutchmed China Ltd - Breakthrough Therapy Designation for HMPL-523
AnnouncementRCS - Hutchmed China Ltd - HUTCHMED Initiates Phase I Study of HMPL-760
AnnouncementREG - Hutchmed China Ltd - Total Voting Rights
AnnouncementREG - Hutchmed China Ltd - Blocklisting Six Monthly Return
AnnouncementRCS - Hutchmed China Ltd - HUTCHMED Included in FTSE Russell Indexes
AnnouncementREG - Hutchmed China Ltd - Grant of Share Options and Awards under LTIP
AnnouncementRCS - Hutchmed China Ltd - HMPL-523 Clinical Data Presented at ASH
AnnouncementRCS - Hutchmed China Ltd - HUTCHMED Presents Data at ESMO Immuno-Oncology ‘21
AnnouncementRCS - Hutchmed China Ltd - HUTCHMED Completes Planned Enrollment of FRESCO-2
AnnouncementREG - Hutchmed China Ltd - Updated NRDL to include ELUNATE and SULANDA
AnnouncementREG - Hutchmed China Ltd - Total Voting Rights
AnnouncementRCS - Hutchmed China Ltd - HUTCHMED and AZ Initiate SACHI Phase 3 Trial
AnnouncementRCS - Hutchmed China Ltd - HUTCHMED to Present Clinical Data at ASH
AnnouncementRCS - Hutchmed China Ltd - HUTCHMED and AZ Initiate SAMETA Global P3 Trial
AnnouncementREG - Hutchmed China Ltd - Total Voting Rights
AnnouncementRCS - Hutchmed China Ltd - HUTCHMED Initiates Phase III Trial of HMPL-523
AnnouncementREG - Hutchmed China Ltd - Grant of Awards under Long Term Incentive Plan
AnnouncementREG - Hutchmed China Ltd - Total Voting Rights
Announcement